Hemophagocytic lymphohistiocytosis secondary to Epstein Barr virus and Leishmania co-infection in a toddler. [caso clínico]
Por: Domínguez Pinilla, Nerea [Pediatría]
| Baro Fernández, María [Pediatría] | González Granados, Luis Ignacio [Pediatría].
Colaborador(es): Servicio de Pediatría-Neonatología.
Tipo de material: 
LibroEditor: Journal of postgraduate medicine, 2015Descripción: 61(1):44-5.Recursos en línea: Acceso libre Resumen: This is the report of an EBV+Leishmanial co-infection. The patient developed hemophagocytic syndrome (HLH) and was treated with the standard HLH-2004 protocol. However, PCR in bone marrow discovered this secondary cause for HLH. In endemic countries, visceral leishmaniasis should be considered in the differential diagnosis even in EBV-related HLH, as chemotherapy toxicity may be avoided.
| Tipo de ítem | Ubicación actual | Signatura | Estado | Fecha de vencimiento |
|---|---|---|---|---|
Caso clínico
|
PC17054 (Navegar estantería) | Disponible |
Formato Vancouver:
DomInguez Pinilla N, Baro Fernández M, González Granado LI. Hemophagocytic lymphohistiocytosis secondary to Epstein Barr virus and Leishmania co-infection in a toddler. J Postgrad Med. 2015 Jan-Mar;61(1):44-5.
PMID: 25511219
PMC4944368
Contiene 6 referencias
This is the report of an EBV+Leishmanial co-infection. The patient developed hemophagocytic syndrome (HLH) and was treated with the standard HLH-2004 protocol. However, PCR in bone marrow discovered this secondary cause for HLH. In endemic countries, visceral leishmaniasis should be considered in the differential diagnosis even in EBV-related HLH, as chemotherapy toxicity may be avoided.
No hay comentarios para este ejemplar.